Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat for ocular inflammation following cataract surgery
NCT01230125Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Nov 2010
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mapracorat in ocular inflammation, sponsored by Bausch + Lomb. Started Nov 2010; status: completed.
02
Drugs
mapracorat
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT01230125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01230125.